163 related articles for article (PubMed ID: 11198298)
21. The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia.
Möddel G; Jacobson B; Ying Z; Janigro D; Bingaman W; González-Martínez J; Kellinghaus C; Prayson RA; Najm IM
Brain Res; 2005 Jun; 1046(1-2):10-23. PubMed ID: 15890316
[TBL] [Abstract][Full Text] [Related]
22. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Ruppe V; Dilsiz P; Reiss CS; Carlson C; Devinsky O; Zagzag D; Weiner HL; Talos DM
Epilepsia; 2014 Apr; 55(4):539-50. PubMed ID: 24512506
[TBL] [Abstract][Full Text] [Related]
23. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis.
Jozwiak J; Jozwiak S; Skopinski P
Histol Histopathol; 2005 Oct; 20(4):1321-6. PubMed ID: 16136513
[TBL] [Abstract][Full Text] [Related]
25. Giant cells in cortical tubers in tuberous sclerosis showing synaptophysin-immunoreactive halos.
Yamanouchi H; Ho M; Jay V; Becker LE
Brain Dev; 1997 Jan; 19(1):21-4. PubMed ID: 9071486
[TBL] [Abstract][Full Text] [Related]
26. CD44 expression in tuberous sclerosis.
Arai Y; Takashima S; Becker LE
Pathobiology; 2000; 68(2):87-92. PubMed ID: 10878505
[TBL] [Abstract][Full Text] [Related]
27. Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions.
Ruffolo G; Iyer A; Cifelli P; Roseti C; Mühlebner A; van Scheppingen J; Scholl T; Hainfellner JA; Feucht M; Krsek P; Zamecnik J; Jansen FE; Spliet WG; Limatola C; Aronica E; Palma E
Neurobiol Dis; 2016 Nov; 95():93-101. PubMed ID: 27425893
[TBL] [Abstract][Full Text] [Related]
28. Role of amino acids in salivation and the localization of their receptors in the rat salivary gland.
Shida T; Kondo E; Ueda Y; Takai N; Yoshida Y; Araki T; Kiyama H; Tohyama M
Brain Res Mol Brain Res; 1995 Nov; 33(2):261-8. PubMed ID: 8750885
[TBL] [Abstract][Full Text] [Related]
29. A comparison of cell phenotypes in hemimegalencephaly and tuberous sclerosis.
Arai Y; Edwards V; Becker LE
Acta Neuropathol; 1999 Oct; 98(4):407-13. PubMed ID: 10502047
[TBL] [Abstract][Full Text] [Related]
30. Role of the NR2A/2B subunits of the N-methyl-D-aspartate receptor in glutamate-induced glutamic acid decarboxylase alteration in cortical GABAergic neurons in vitro.
Monnerie H; Hsu FC; Coulter DA; Le Roux PD
Neuroscience; 2010 Dec; 171(4):1075-90. PubMed ID: 20923697
[TBL] [Abstract][Full Text] [Related]
31. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
33. Laminar and cellular distribution of AMPA, kainate, and NMDA receptor subunits in monkey sensory-motor cortex.
Muñoz A; Woods TM; Jones EG
J Comp Neurol; 1999 May; 407(4):472-90. PubMed ID: 10235640
[TBL] [Abstract][Full Text] [Related]
34. Significance of tuber size for complications of tuberous sclerosis complex.
Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
[TBL] [Abstract][Full Text] [Related]
35. Evidence of abnormal differentiation in giant cells of tuberous sclerosis.
Yamanouchi H; Jay V; Rutka JT; Takashima S; Becker LE
Pediatr Neurol; 1997 Jul; 17(1):49-53. PubMed ID: 9308976
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of alpha3-containing GABAA receptors in the neocortex of patients with focal epilepsy.
Loup F; Picard F; André VM; Kehrli P; Yonekawa Y; Wieser HG; Fritschy JM
Brain; 2006 Dec; 129(Pt 12):3277-89. PubMed ID: 17046856
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
Crino PB
J Child Neurol; 2004 Sep; 19(9):716-25. PubMed ID: 15563019
[TBL] [Abstract][Full Text] [Related]
38. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
39. Developmental lineage of cell types in cortical dysplasia with balloon cells.
Lamparello P; Baybis M; Pollard J; Hol EM; Eisenstat DD; Aronica E; Crino PB
Brain; 2007 Sep; 130(Pt 9):2267-76. PubMed ID: 17711980
[TBL] [Abstract][Full Text] [Related]
40. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
